Literature DB >> 23797723

Molecular and histopathologic characteristics of multifocal papillary thyroid carcinoma.

Mona Bansal1, Manoj Gandhi, Robert L Ferris, Marina N Nikiforova, Linwah Yip, Sally E Carty, Yuri E Nikiforov.   

Abstract

Papillary thyroid carcinoma (PTC) is frequently multifocal, which can represent either intraglandular spread from a single primary tumor or multiple synchronous primary tumors (MSPTs). To distinguish and characterize these entities, we investigated whether multifocal PTCs contain genetically similar or different mutations and have particular histopathologic characteristics. In 60 cases of PTC with 2 to 4 discrete tumor foci, each focus was tested for BRAF, NRAS, HRAS, and KRAS point mutations and RET/PTC1 and RET/PTC3 rearrangements and analyzed for various histopathologic features. Overall, BRAF mutations were found in 43% of tumors, RAS in 27%, and RET/PTC in 2%. Four different patterns of mutation occurrence were identified: (i) 2 foci containing different mutations (30%); (ii) 1 tumor containing a mutation and another carrying no mutations (32%); (iii) both/all tumors containing the same mutation (25%); (iv) all tumors having no mutations (13%). The 30% of cases with 2 different mutations represent a group of tumors that are unequivocally MSPT. These tumors more commonly occurred in different lobes, although they could be located as close as 0.6 cm from each other. Moreover, MSPTs typically demonstrated distinct histologic variants/microscopic features, were encapsulated or had a smooth border, and showed no microscopic peritumoral dissemination. In conclusion, we demonstrate that at least 30% of multifocal PTCs represent unequivocal MSPTs that develop through distinct molecular alterations and that as many as 60% of multifocal PTCs are likely MSPTs. Histopathologically, MSPTs are typically located in different lobes, have distinct growth patterns, and do not show microscopic peritumoral dissemination.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23797723     DOI: 10.1097/PAS.0b013e318292b780

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  23 in total

1.  BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study.

Authors:  Giovanni Tallini; Dario de Biase; Cosimo Durante; Giorgia Acquaviva; Michele Bisceglia; Rocco Bruno; Maria Letizia Bacchi Reggiani; Gian Piero Casadei; Giuseppe Costante; Nadia Cremonini; Livia Lamartina; Domenico Meringolo; Francesco Nardi; Annalisa Pession; Kerry J Rhoden; Giuseppe Ronga; Massimo Torlontano; Antonella Verrienti; Michela Visani; Sebastiano Filetti
Journal:  Mod Pathol       Date:  2015-08-14       Impact factor: 7.842

2.  Clinical characteristics and surgical resection of multifocal papillary thyroid carcinoma: 168 cases.

Authors:  Guomin Huang; Xiaofeng Tian; Yuhui Li; Fujian Ji
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  An alternative approach in endocrine pathology research: MALDI-IMS in papillary thyroid carcinoma.

Authors:  Veronica Mainini; Fabio Pagni; Mattia Garancini; Vittorio Giardini; Gabriele De Sio; Carlo Cusi; Cristina Arosio; Gaia Roversi; Clizia Chinello; Paola Caria; Roberta Vanni; Fulvio Magni
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

4.  Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma.

Authors:  Junliang Lu; Jie Gao; Jing Zhang; Jian Sun; Huanwen Wu; Xiaohua Shi; Lianghong Teng; Zhiyong Liang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

5.  Clinical importance of bilateral disease in patients with papillary thyroid cancer.

Authors:  Sarah E Moore; Katayoon Kasaian; Steven Jones; Adrienne Melck; Sam M Wiseman
Journal:  Can J Surg       Date:  2016-06       Impact factor: 2.089

Review 6.  Clinical application of molecular testing of fine-needle aspiration specimens in thyroid nodules.

Authors:  Linwah Yip; Robert L Ferris
Journal:  Otolaryngol Clin North Am       Date:  2014-06-12       Impact factor: 3.346

7.  Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer.

Authors:  Abbas Ali Tam; Didem Özdemir; Neslihan Çuhacı; Hüsniye Başer; Cevdet Aydın; Aylin Kılıç Yazgan; Reyhan Ersoy; Bekir Çakır
Journal:  Endocrine       Date:  2016-04-18       Impact factor: 3.633

8.  Using foci number to predict central lymph node metastases of papillary thyroid microcarcinomas with multifocality.

Authors:  Yawen Guo; Zeming Liu; Pan Yu; Chunping Liu; Jie Ming; Ning Zhang; Maimaiti Yusufu; Chen Chen; Tao Huang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

9.  Anaplastic Transformation of Papillary Thyroid Carcinoma in a Young Man: A Case Study with Immunohistochemical and BRAF Analysis.

Authors:  Ji Hye Park; Hyeong Ju Kwon; Cheong Soo Park; SoonWon Hong
Journal:  Korean J Pathol       Date:  2014-06-26

Review 10.  The MAPK pathway across different malignancies: a new perspective.

Authors:  Mauricio Burotto; Victoria L Chiou; Jung-Min Lee; Elise C Kohn
Journal:  Cancer       Date:  2014-06-19       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.